美施康定

192例晚期癌症病人美施康定止痛临床观察

An observation of 192 advanced cancer patients treated with MS contin for pain relief

结果：美施康定用量逐年增加，其他品种用量变化较小。

Results : The assumption of MS CONTIN increased year after year , and other varieties showed a steady tendency .

方法将126例中、重度癌症疼痛的患者随机分两组，分别接受多瑞吉（A组）与美施康定（B组）治疗，并记录其疗效、副作用及生存质量。

Methods 126 patients were randomized into Durogesic group ( group A ) and MS-Contin group ( group B ) . The two groups received Durogesic and MS-contin respectively .

结果：除美施康定（吗啡控释片）DUI1外，其他药品DUI均小于1。结论：吗啡作为WHO评价改善癌痛状态的指标，在我院用量偏小。

Results : DUI of Mscountin ( Morphine controlled release tablets ) was 1.DUI of the other drugs was 1 . Conclusion : As the evaluation indicator of WHO cancer complaint amendment , the dosage of Morphin was low in our hospital .

除芬太尼、美施康定DUI1外，其他DuI均l。结论：本院麻醉性镇痛药用于癌痛基本合理，但部分品种的用药剂量偏小。

Except MS CONTIN and Fentanyl , DUI of the other anesthetic analgesics were below 1 . Conclusion : The use of anesthetic analgesics for cancer pain was rational on the whole , but the dosages of part of the analgesics were rather small .

美施康定治疗重度癌痛疗效观察

Clinical study of MS Contin for the severe cancer pain

美施康定直肠给药在胸外科手术后的应用

The clinical use of MS Contin via recta after thoracic surgery operation

美施康定治疗晚期癌痛72例临床分析

Treatment of Pain in Late Stage Cancer by MS-Contin-Clinical Analysis of 72 Cases

美施康定致尿潴留36例临床观察及护理

Clinical observation and nursing care of 36 cases of Morphine induced urinary retention

美施康定控制晚期肿瘤癌性疼痛69例临床疗效分析

Clinic Analysis of Controlling Advanced Cancer Pain on 69 Cases by Ms Contin

美施康定直肠给药应用于腹部手术后镇痛的临床观察

The Clinical Study of Rectum Administration of MS Contin for Analgesia After Abdomen Operation

目的观察美施康定直肠给药治疗癌症疼痛的止痛效果。

Objective To evaluate the analgesic effect of treating cancer pain by MS-contin administered rectally .

目的研究美施康定对晚期癌症的镇痛效果及副作用。

Objective To study the analgesia in advanced cancer with Ms contin and its toxicity .

结果：多瑞吉与美施康定治疗中重度癌痛的有效率分别为83.7%和81.6%。

Results The pain remission rate of group Durogesic was 83.7 % and that of group MS contin 81.6 % .

目的：评价美施康定治疗晚期癌症病人中、重度癌痛的疗效。

Objective : To observe the response and adverse reactions of MS contin ( controlled-release morphine sulfate ) to treat severe pain in cancer patients .

目的：本研究比较单用芬太尼透皮贴进行剂量滴定和先用美施康定进行剂量滴定后用芬太尼透皮贴自身对照进行晚期癌症疼痛治疗的方法比较。

Objective : To compare the effect of single Durogesic dosage titration and us-ing MS-contin dosage titration first followed by Durogesic self-control in management of advanced cancer pain .

用量最大的和处方频数最高的是可待因，金额排序第一的是美施康定。

The results showed that the largest quantity used and frequency of prescription were due to codeine , the order of sum as first was due to MS-Contine .

方法应用美施康定片（硫酸吗啡控释片）临床治疗36例，8例经口服给药，但因术后病人无法进食或进食较晚，后改为直肠给药。

Methods : we use MS Contin ( Morphine sulphate controlled release tablets ) in 36 cases , of which , 8 patients were given the medicine orally and the rest of all were given via recta .

方法对71例晚期癌症患者，使用美施康定进行长期随访研究，观察对癌症患者中、重度疼痛的镇痛效果，药物的初次剂量和最大剂量、增加剂量的分布及副作用。

Methods A randomized study was done in 71 patients with advanced cancer who received analgesic comparing the efficacy , primary dose , maximum dose , distribution of raised dose and the toxity of mMs contin group .